loadpatents
name:-0.039376974105835
name:-0.036044120788574
name:-0.012978076934814
Popel; Aleksander S. Patent Filings

Popel; Aleksander S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Popel; Aleksander S..The latest application filed is for "peptide/particle delivery systems".

Company Profile
6.16.23
  • Popel; Aleksander S. - Lutherville MD
  • POPEL; Aleksander S. - Baltimore MD
  • POPEL; ALEKSANDER S. - LUTHERVILLE-TIMONIUM MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
Grant 11,155,603 - Popel , et al. October 26, 2
2021-10-26
Peptide/particle Delivery Systems
App 20210220287 - Green; Jordan Jamieson ;   et al.
2021-07-22
Methods For Identifying And Preparing Pharmaceutical Agents For Activating Tie2 Receptor
App 20210132062 - PANDEY; Niranjan ;   et al.
2021-05-06
Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases
App 20200361993 - POPEL; ALEKSANDER S. ;   et al.
2020-11-19
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases
App 20200362017 - POPEL; ALEKSANDER S. ;   et al.
2020-11-19
Peptide/particle delivery systems
Grant 10,786,463 - Green , et al. September 29, 2
2020-09-29
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
Grant 10,774,112 - Popel , et al. Sept
2020-09-15
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases
Grant 10,774,131 - Popel , et al. Sept
2020-09-15
Biodegradable Microparticles For Sustained Delivery Of Anti-angiogenic Peptide
App 20200179285 - GREEN; Jordan J. ;   et al.
2020-06-11
Compounds And Methods For Activating Tie2 Signaling
App 20190225670 - Pandey; Niranjan B. ;   et al.
2019-07-25
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases
App 20190002531 - POPEL; ALEKSANDER S. ;   et al.
2019-01-03
Peptides With Anti-angiogenic, Anti-lymphangiogenic, And Anti-edemic Properties And Nanoparticle Formulations
App 20180339024 - BRESSLER; Eric M. ;   et al.
2018-11-29
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases
Grant 10,106,597 - Popel , et al. October 23, 2
2018-10-23
Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases
App 20180134753 - POPEL; ALEKSANDER S. ;   et al.
2018-05-17
Peptide/particle Delivery Systems
App 20180028455 - Green; Jordan Jamieson ;   et al.
2018-02-01
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
Grant 9,802,984 - Popel , et al. October 31, 2
2017-10-31
Peptide/particle delivery systems
Grant 9,717,694 - Green , et al. August 1, 2
2017-08-01
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases
App 20170174749 - POPEL; ALEKSANDER S. ;   et al.
2017-06-22
Peptide/particle Delivery Systems
App 20160374949 - Green; Jordan Jamieson ;   et al.
2016-12-29
A Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases
App 20160122390 - POPEL; ALEKSANDER S. ;   et al.
2016-05-05
Compositions having antiangiogenic activity and uses thereof
Grant 9,187,539 - Popel , et al. November 17, 2
2015-11-17
Peptide modulators of angiogenesis and use thereof
Grant 9,187,544 - Popel , et al. November 17, 2
2015-11-17
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases
App 20150307592 - POPEL; ALEKSANDER S. ;   et al.
2015-10-29
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases
Grant 9,056,923 - Popel , et al. June 16, 2
2015-06-16
Peptide Modulators Of Angiogenesis And Use Thereof
App 20140100164 - Popel; Aleksander S. ;   et al.
2014-04-10
Compositions Having Antiangiogenic Activity And Uses Thereof
App 20140045757 - Popel; Aleksander S. ;   et al.
2014-02-13
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphagiogenesis-dependent Diseases
App 20130316950 - Popel; Aleksander S. ;   et al.
2013-11-28
Compositions having antiangiogenic activity and uses thereof
Grant 8,557,772 - Popel , et al. October 15, 2
2013-10-15
Peptide modulators of angiogenesis and use thereof
Grant 8,507,434 - Popel , et al. August 13, 2
2013-08-13
Compositions Having Antiangiogenic Activity And Uses Thereof
App 20120232012 - Popel; Aleksander S. ;   et al.
2012-09-13
Peptide/particle Delivery Systems
App 20120114759 - Green; Jordan Jamieson ;   et al.
2012-05-10
Peptide Modulators Of Angiogenesis And Use Thereof
App 20110028395 - Popel; Aleksander S. ;   et al.
2011-02-03
Compositions Having Antiangiogenic Activity and Uses Thereof
App 20100144641 - Popel; Aleksander S. ;   et al.
2010-06-10
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed